{
  "name": "US labeling routes for unapproved IVD products shipped for research or testing (21 CFR 809.10(c))",
  "description": "Compares the three shipment routes in 21 CFR 809.10(c): investigation under part 812, research use only, and investigational use only, with the exact required label wording and the condition for each. Compiled from the regulation text and FDA's 2013 guidance.",
  "page": "https://casrai.org/guides/research-use-only",
  "publisher": "CASRAI",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "dateModified": "2026-11-17T23:19:15Z",
  "temporalCoverage": null,
  "spatialCoverage": "United States",
  "columns": [
    {
      "name": "Route",
      "unit": "",
      "description": ""
    },
    {
      "name": "Regulation paragraph",
      "unit": "",
      "description": ""
    },
    {
      "name": "Development stage or condition",
      "unit": "",
      "description": ""
    },
    {
      "name": "Required label statement",
      "unit": "",
      "description": ""
    }
  ],
  "rows": [
    {
      "Route": "Research use only (RUO)",
      "Regulation paragraph": "21 CFR 809.10(c)(2)(i)",
      "Development stage or condition": "Product in the laboratory research phase of development, not represented as an effective in vitro diagnostic product, and not subject to part 812",
      "Required label statement": "For Research Use Only. Not for use in diagnostic procedures."
    },
    {
      "Route": "Investigational use only (IUO)",
      "Regulation paragraph": "21 CFR 809.10(c)(2)(ii)",
      "Development stage or condition": "Product testing before full commercial marketing, not subject to part 812",
      "Required label statement": "For Investigational Use Only. The performance characteristics of this product have not been established."
    },
    {
      "Route": "Part 812 investigation",
      "Regulation paragraph": "21 CFR 809.10(c)(1)",
      "Development stage or condition": "Investigation subject to part 812, with the shipment complying with part 812",
      "Required label statement": "Governed by part 812 (investigational device exemption)"
    }
  ],
  "sources": [
    {
      "title": "21 CFR 809.10",
      "url": "https://www.law.cornell.edu/cfr/text/21/809.10",
      "accessed": "2026-11-17"
    },
    {
      "title": "FDA guidance: Distribution of IVD Products Labeled for RUO or IUO",
      "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/distribution-in-vitro-diagnostic-products-labeled-research-use-only-or-investigational-use-only",
      "accessed": "2026-11-17"
    }
  ]
}